Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaafar Ragab

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Frontiers in Medicine|December 27, 2023
Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's DiseaseAntonio Vitale, Valeria Caggiano, Petros P Sfikakis, et al.
Frontiers in Pharmacology|March 6, 2025
Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registryAntonio Vitale, Valeria Caggiano, Flavia Leone, et al.
Frontiers in Pharmacology|March 24, 2025
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA networkAntonio Vitale, Flavia Leone, Valeria Caggiano, et al.
Frontiers in Medicine|April 25, 2022
Development and Implementation of the AIDA International Registry for Patients With Still's DiseaseAntonio Vitale, Francesca Della Casa, Giuseppe Lopalco, et al.
Frontiers in Medicine|January 28, 2026
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registriesValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Rheumatology (Oxford, England)|July 14, 2026
Effectiveness and probability of full disease control with canakinumab in familial Mediterranean fever: real-world data from the AIDA NetworkAntonio Vitale, Valeria Caggiano, Jessica Sbalchiero, et al.
Rheumatology (Oxford, England)|April 2, 2025
Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network RegistryAntonio Vitale, Valeria Caggiano, Jessica Sbalchiero, et al.
Frontiers in Medicine|July 3, 2023
A patient-driven registry on Behçet's disease: the AIDA for patients pilot projectCarla Gaggiano, Alessandra Del Bianco, Jurgen Sota, et al.
Seminars in Arthritis and Rheumatism|July 30, 2023
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease RegistryPiero Ruscitti, Jurgen Sota, Antonio Vitale, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2024
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Frontiers in Medicine|December 27, 2023
Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's DiseaseAntonio Vitale, Valeria Caggiano, Petros P Sfikakis, et al.
Frontiers in Pharmacology|March 6, 2025
Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registryAntonio Vitale, Valeria Caggiano, Flavia Leone, et al.
Frontiers in Pharmacology|March 24, 2025
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA networkAntonio Vitale, Flavia Leone, Valeria Caggiano, et al.
Frontiers in Medicine|April 25, 2022
Development and Implementation of the AIDA International Registry for Patients With Still's DiseaseAntonio Vitale, Francesca Della Casa, Giuseppe Lopalco, et al.
Frontiers in Medicine|January 28, 2026
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registriesValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Rheumatology (Oxford, England)|July 14, 2026
Effectiveness and probability of full disease control with canakinumab in familial Mediterranean fever: real-world data from the AIDA NetworkAntonio Vitale, Valeria Caggiano, Jessica Sbalchiero, et al.
Rheumatology (Oxford, England)|April 2, 2025
Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network RegistryAntonio Vitale, Valeria Caggiano, Jessica Sbalchiero, et al.
Frontiers in Medicine|July 3, 2023
A patient-driven registry on Behçet's disease: the AIDA for patients pilot projectCarla Gaggiano, Alessandra Del Bianco, Jurgen Sota, et al.
Seminars in Arthritis and Rheumatism|July 30, 2023
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease RegistryPiero Ruscitti, Jurgen Sota, Antonio Vitale, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2024
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Pageof 9